Synchronous Late-Onset of Limbic Encephalitis and Tumefactive Demyelinating Lesion After the End of Immunotherapy
{{output}}
Immunoreactive encephalitis is a very rare side effect of immunotherapy, which can lead to severe morbidity. Following azetolizumab, it typically occurs within 0-12 months, with a median of 15 days. In this case, immunoreactive encephalitis occurred 3.5 months... ...
